Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Net Income: 2016-2024

Historic Net Income for Cidara Therapeutics (CDTX) over the last 9 years, with Dec 2024 value amounting to $464,000.

  • Cidara Therapeutics' Net Income fell 18396.22% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.4 million, marking a year-over-year decrease of 2564.97%. This contributed to the annual value of $464,000 for FY2024, which is 78.41% down from last year.
  • As of FY2024, Cidara Therapeutics' Net Income stood at $464,000, which was down 78.41% from $2.1 million recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Net Income ranged from a high of $2.1 million in FY2023 and a low of -$72.1 million during FY2020.
  • Over the past 3 years, Cidara Therapeutics' median Net Income value was $464,000 (recorded in 2024), while the average stood at -$10.3 million.
  • Per our database at Business Quant, Cidara Therapeutics' Net Income soared by 106.40% in 2023 and then slumped by 78.41% in 2024.
  • Cidara Therapeutics' Net Income (Yearly) stood at -$72.1 million in 2020, then skyrocketed by 41.11% to -$42.5 million in 2021, then climbed by 20.92% to -$33.6 million in 2022, then surged by 106.40% to $2.1 million in 2023, then crashed by 78.41% to $464,000 in 2024.